Zevra Therapeutics, Inc. ZVRA Business Segments — Depreciation and amortization expense

Similar metrics at other companies

ACHRReportable Segment — Depreciation and amortization expense

$7.8M+90.2%

OPCHReportable Segment — Depreciation and amortization expense

$14.91M-5.3%

TARSReportable Segment — Depreciation and amortization expense

-$437K+5.0%

GOReportable Segment — Depreciation and amortization expenses

$31.16M+4.2%

SHAKReportable Segment — Depreciation and amortization expense

$29.12M+9.7%

RXOReportable Segment — Depreciation and amortization expense

$26M-18.8%

Questions, answered.

What is Zevra Therapeutics, Inc.'s business segments — depreciation and amortization expense?

Zevra Therapeutics, Inc. (ZVRA) reported business segments — depreciation and amortization expense of $368K in Q1 2026.

How has Zevra Therapeutics, Inc.'s business segments — depreciation and amortization expense changed year-over-year?

Zevra Therapeutics, Inc.'s business segments — depreciation and amortization expense decreased by 77.7% year-over-year, from $1.65M to $368K.

What does business segments — depreciation and amortization expense mean?

Represents the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the segment. This metric is critical for understanding the capital intensity of the segment and its underlying asset base.